ETHYL 5-AMINO-1-(QUINOXALIN-2-YL)-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 250mg

1-(5-Methoxypyrazin-2-yl)ethanone, 98+%, 250mg

1,2-Diphenyl-1H-benzo[d]imidazole, 95%, 1g

6-Aminonicotinamide>99.0%(T)5g

4-Methylpentan-2-ol, 95.0%, 500g

2-(1-Cyclopentenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)5g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

4-(2,5-Dichlorophenyl)-4-oxobutyric acid, 97.0%, 1g

Propyl Benzoate>99.0%(GC)25mL

[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]amine dihydrochloride hydrate, 95.0%, 1g

Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester, 97%, 250mg

2-Pyrazinecarboxylic acid, 99.00%, 100g

6-Bromo-1-methylindoline-2,3-dione, 95%, 1g